Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro activity against SARS-CoV-2. (2022)
Attributed to:
New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ijantimicag.2022.106542
PubMed Identifier: 35093538
Publication URI: http://europepmc.org/abstract/MED/35093538
Type: Journal Article/Review
Volume: 59
Parent Publication: International journal of antimicrobial agents
Issue: 3
ISSN: 0924-8579